Donor-type Myelodysplastic Syndrome with T(2;3) and Monosomy 7 After Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-type Aplastic Anemia
Overview
Authors
Affiliations
Secondary clonal hemaloiogical disease in donor cells has rarely been reported as a complication of allogeneic stem cell transplantation in hematological disease. We report a case of myelodysplastic syndrome that showed cytogenetic abnormalities of t(2;3) and monosomy 7, which developed 2 years after peripheral blood stem cell transplantation for aplastic anemia and 1 year after liver transplantation for drug-induced hepatic failure. This secondary malignancy of donor origin is most frequently seen in patients with leukemia. We suspect that the chromosomal abnormalities are related to hepatitis-associated aplastic anemia, administration of granulocyte colony-stimulating factor and erythropoietin for posttransplantion pancytopenia, and repeated infections after liver transplantation.
Deshmukh K, Kelemen K Life (Basel). 2022; 12(4).
PMID: 35455050 PMC: 9028156. DOI: 10.3390/life12040559.
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.
Williams L, Doucette K, Karp J, Lai C Bone Marrow Transplant. 2021; 56(7):1535-1549.
PMID: 33686252 DOI: 10.1038/s41409-021-01214-z.
Manivannan P, Purohit A, Somasundaram V, Ahuja A, Aggarwal M, Kumar R Indian J Hematol Blood Transfus. 2016; 32(Suppl 1):223-7.
PMID: 27408397 PMC: 4925474. DOI: 10.1007/s12288-014-0484-z.
Ma H, Liu T Oncol Lett. 2016; 11(6):3858-3862.
PMID: 27313707 PMC: 4888078. DOI: 10.3892/ol.2016.4452.
Otero L, Correa de Souza D, de Cassia Tavares R, Gomes B, Padilha T, Bouzas L Genet Mol Biol. 2012; 35(4):734-6.
PMID: 23271931 PMC: 3526078. DOI: 10.1590/S1415-47572012005000056.